Microfluidics for Diagnostic ApplicationsRegister now
FREE WEBCAST – April 25 at 5:00 PM CET
Share this webcast with your colleagues !
Microfluidics for Diagnostic Applications
Who leads the market? Who holds the IP?
During the last few years, Yole has observed strong maturation within the microfluidics industry. For a time, next-generation sequencing applications drove market growth and strategic moves, but now microfluidics is making significant contributions to the expansion of somediagnostics segments. This year, KnowMade and Yole joined forces to develop a comprehensive analysis of the microfluidics world in terms of market, technology, and IP. This webcast presents some of the results from our analysis, focusing on diagnostics applications in order to explain how and why microfluidic technologies are increasingly used, and their many benefits.
This webcast help you understand:
- How the microfluidics landscape has changed over the last two years
- How the latest microfluidics strategic moves within the diagnostics industry will influence the market
- The current market size and how we see the future unfolding
- The specific sweet spots where microfluidic technologies offer high added-value, and why
- How the IP landscape is organized, and the IP strategy of various main players
Sébastien Clerc, Medical Technologies Market & Technology Analyst, Yole Développement
Sébastien Clerc is a Medical Technologies Analyst at Yole Développement, the “More than Moore” market research and strategy consulting company. After graduating from Grenoble INP with a Biomedical Technologies Master degree, he completed his training with a Master degree in Innovation and Technology Management, during which he oversaw strategy and marketing
Coralie Le Greneur, Patent & Technology Analyst, Knowmade
Dr Coralie Le Greneur works for Knowmade in the field of Biotechnology and Life Sciences. She holds a PhD in Molecular Biology from the University of Nice Sophia-Antipolis (France). She also holds the International Industrial Studies Diploma in Patents from the CEIPI, Strasbourg (France).
Benjamin Roussel, Microfluidic and Medical Technologies Business Unit Manager, Yole Développement
Dr Benjamin Roussel is Business Unit Manager of the Microfluidic & Medical Technologies (MedTech) activities at Yole Développement, the “More than Moore” market research and strategy consulting company. Supporting industrial companies and R&D institutes in their development, Benjamin and his team are making the bridge between innovative microtechnologies and numerous diagnostics, pharmaceutical, life sciences and medical devices applications. Benjamin Roussel is the author of a large collection of market & technology reports focusing on bioMEMS, microfluidics and solid state medical imaging and performs multiple custom consulting projects. Thanks to its deep knowledge of these industries and related technologies, he has spoken in more than 20 industry conferences worldwide over the last 5 years. Before joining Yole, Benjamin worked in an International Pharmaceutical company in the pharmacovigilance department. He holds a Pharmacy diploma from the University Claude Bernard Lyon (France), in addition to a master’s degree in Technology & Innovation Management from EM Lyon Business School (France).
Discover the related reports about the Microfluidic Industry here
Contact: Clotilde Fabre (email@example.com)